Mechanism of Action of Secukinumab
Introduction Secukinumab is a biologic immunomodulator marketed under the brand name Cosentyx. Pharmacologically, it is a human interleukin-17A antagonist and a recombinant human IgG1 kappa monoclonal antibody. Interleukin-17A, commonly called IL-17A, is a pro-inflammatory cytokine involved in immune defense and chronic inflammatory disease. It is produced mainly by Th17 cells, but other immune cells such … Read more